Our Blog

Forum on Healthcare Innovation Speech

Posted by Danielle on January 23, 2015

WHO WE ARE /WHAT WE DO

Thank you for having me. My name is Dan Hogan, founder and CEO of Medalogix—

I thought I’d start with WHO WE ARE then get into WHAT WE DO and WHY IT’S IMPORTANT TO PATIENTS AND THE OVERALL HEALTHCARE SYSTEM.

First, by way of background I used to own a home healthcare agency just outside of Nashville. In 2009/2010 amidst healthcare reforms, I began exploring the idea of analyzing patient data to determine if there were elements in that data that could predict which patients were most likely to be readmitted to the hospital. With this knowledge, we could intervene before a readmission occurred.

And it worked! It was highly predictive.

Fast forward a couple of years to 2012, we are already in the market with a predictive solution geared towards readmission prevention and we said, “This readmission tool is impressive but you know what would be great? If we could tell us which patients were likely to pass away, providers could do a better job of offering palliative care or hospice options to those patients.”

This is an important problem because so many of us die in the hospital pursuing low probability highly uncomfortable options that aren’t working. A rather renowned Harvard alum, Atul Gawande’s book, “Being Mortal” speaks to this very topic.

So we took on the challenge…and it worked again.

Today that tool is Medalogix Bridge, which provides an evidenced-based risk analysis, coupled with customized workflow. The whole point of this is to prompt end of life conversations with the right patients earlier so they have more time to live the end of their lives the way they want to.

HOW WE KNOW IT WORKS

Vanderbilt just released 2 abstracts summarizing their analysis of the effectiveness of Bridge. They concluded:

  • Home care agencies using Bridge have reduced the rate at which patients are dying on their home care censuses by 52%
  • Patients tend to come to hospice too late. These same agencies have seen a 30% drop in the early death of patients on hospice. We are identifying them sooner.

WHAT DOES THIS MEAN FOR PATIENTS AND OUR HEALTHCARE SYSTEM

If scaled to every level of the acuity ladder, Bridge could help find the right care venue for nearly 38K patients in HHA, 90K in SNF and another 90K in the acute space generating more than $2B in annual savings to the system.

This is important work …not because of the cost savings but because it has the potential to impact the way we all die.

   

Recent Posts